Qube Research & Technologies (QRT)
VERA icon

Qube Research & Technologies (QRT)’s Vera Therapeutics VERA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.8M Buy
541,799
+163,744
+43% +$7.05M 0.03% 835
2025
Q4 		$19.1M Sell
378,055
-83,355
-18% -$2.96M 0.03% 938
2025
Q3 		$13.4M Buy
461,410
+149,468
+48% +$3.46M 0.02% 1134
2025
Q2 		$7.35M Sell
311,942
-32,681
-9% -$735K 0.01% 1476
2025
Q1 		$8.28M Buy
344,623
+174,137
+102% +$5.6M 0.01% 1249
2024
Q4 		$7.21M Buy
170,486
+157,110
+1,175% +$6.96M 0.01% 1298
2024
Q3 		$591K Buy
+13,376
New +$508K ﹤0.01% 2209
2024
Q2 		– Sell
-20,356
Closed -$878K – 4776
2024
Q1 		$878K Buy
+20,356
New +$725K ﹤0.01% 2225

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return